Cardiff Oncology Dividends
| CRDF Stock | USD 1.61 0.00 0.00% |
The current Dividends Paid is estimated to decrease to about 354 K. The current Dividend Yield is estimated to decrease to 0.01. Cardiff Oncology's past performance could be the main factor of why investors trade Cardiff Oncology stock today. Investors should clearly understand every aspect of the Cardiff Oncology dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Cardiff Oncology's dividend schedule and payout information. Cardiff Oncology dividends can also provide a clue to the current valuation of Cardiff Oncology.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 372.6 K | 354 K | |
| Dividend Yield | 0.01 | 0.01 | |
| Dividend Payout Ratio | (0.01) | (0.01) | |
| Dividend Paid And Capex Coverage Ratio | (424.05) | (402.84) |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Cardiff Oncology must own a stock before its ex-dividend date to receive its next dividend.
Cardiff Oncology Dividends Paid Over Time
Today, most investors in Cardiff Oncology Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Cardiff Oncology's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Cardiff Oncology dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Cardiff Oncology Historical Dividend Yield Growth
A solid dividend growth pattern of Cardiff Oncology could indicate future dividend growth is likely, which can signal long-term profitability for Cardiff Oncology. When investors calculate the dividend yield growth rate, they can use any interval of time they wish. They may also calculate the dividend yield growth rate using the least-squares method or simply take an annualized figure over a given time period. Dividend Yield is Cardiff Oncology dividend as a percentage of Cardiff Oncology stock price. Cardiff Oncology dividend yield is a measure of Cardiff Oncology stock productivity, which can be interpreted as interest rate earned on an Cardiff Oncology investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share. Dividend Yield |
| Timeline |
Can Biotechnology industry sustain growth momentum? Does Cardiff have expansion opportunities? Factors like these will boost the valuation of Cardiff Oncology. Projected growth potential of Cardiff fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Cardiff Oncology demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (0.79) | Revenue Per Share | Quarterly Revenue Growth (0.27) | Return On Assets | Return On Equity |
Understanding Cardiff Oncology requires distinguishing between market price and book value, where the latter reflects Cardiff's accounting equity. The concept of intrinsic value - what Cardiff Oncology's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push Cardiff Oncology's price substantially above or below its fundamental value.
It's important to distinguish between Cardiff Oncology's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cardiff Oncology should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Cardiff Oncology's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.